肺腺癌与肺鳞状细胞癌基因表达亚型在肿瘤免疫微环境中显示显著差异
研究利用已发表的免疫细胞特征及多个肺腺癌(AD)和肺鳞状细胞癌(SCC)基因表达数据集(包括癌症基因组图谱),分析免疫反应与AD和SCC表达亚型的关系。结果显示,AD和SCC表达亚型在肿瘤免疫微环境中存在显著差异;在SCC中,肿瘤表达亚型比CD274(程序性死亡配体1)更能预测免疫细胞表达,但在AD中两者预测能力相当。非沉默突变负荷与免疫细胞表达不相关,而主要组织相容性复合体II类基因表达与免疫细胞表达高度相关。免疫及MHC II类基因表达增加与AD的末端呼吸单位亚型和近端炎症亚型以及SCC的原始亚型生存改善相关。
要点
- 肺腺癌近端增殖亚型免疫细胞表达低,而肺鳞癌分泌亚型免疫细胞表达升高。
- 在鳞癌中,肿瘤表达亚型比CD274更能预测免疫细胞表达;在腺癌中两者相当。
- 免疫及MHC II类基因表达增加与腺癌末端呼吸单位、近端炎症亚型及鳞癌原始亚型生存改善相关。
核心结论
- 肺腺癌和肺鳞癌的分子表达亚型在宿主免疫反应中显示出关键且可重复的差异。
研究设计与样本
- 研究使用已发表的免疫细胞特征和多个肺腺癌与肺鳞癌基因表达数据集(包括癌症基因组图谱),分析免疫反应与AD和SCC表达亚型的关系。
主要发现
- 肺腺癌和肺鳞癌表达亚型在肿瘤免疫微环境中表现出显著差异。
- 肺腺癌近端增殖亚型在AD中免疫细胞表达低,而鳞癌分泌亚型在SCC中免疫细胞表达升高。
- 在鳞癌肿瘤中,肿瘤表达亚型比CD274(程序性死亡配体1)更能预测免疫细胞表达;在腺癌肿瘤中两者预测能力相当。
- 非沉默突变负荷与各亚型免疫细胞表达不相关;主要组织相容性复合体II类基因表达与免疫细胞表达高度相关。
- 免疫及MHC II类基因表达增加与腺癌末端呼吸单位亚型和近端炎症亚型以及鳞癌原始亚型的生存改善相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Molecular subtyping of lung adenocarcinoma (AD) and lung squamous cell carcinoma (SCC) reveal biologically diverse tumors that vary in their genomic and clinical attributes. METHODS: Published immune cell signatures and several lung AD and SCC gene expression data sets, including The Cancer Genome Atlas, were used to examine immune response in relation to AD and SCC expression subtypes. Expression of immune cell populations and other immune related genes, including CD274 molecule gene (CD274) (programmed death ligand 1), was investigated in the tumor microenvironment relative to the expression subtypes of the AD (terminal respiratory unit, proximal proliferative, and proximal inflammatory) and SCC (primitive, classical, secretory, and basal) subtypes. RESULTS: Lung AD and SCC expression subtypes demonstrated significant differences in tumor immune landscape. The proximal proliferative subtype of AD demonstrated low immune cell expression among ADs whereas the secretory subtype showed elevated immune cell expression among SCCs. Tumor expression subtype was a better predictor of immune cell expression than CD274 (programmed death ligand 1) in SCC tumors but was a comparable predictor in AD tumors. Nonsilent mutation burden was not correlated with immune cell expression across subtypes; however, major histocompatibility complex class II gene expression was highly correlated with immune cell expression. Increased immune and major histocompatibility complex II gene expression was associated with improved survival in the terminal respiratory unit and proximal inflammatory subtypes of AD and in the primitive subtype of SCC. CONCLUSIONS: Molecular expression subtypes of lung AD and SCC demonstrate key and reproducible differences in immune host response. Evaluation of tumor expression subtypes as potential biomarkers for immunotherapy should be investigated.
引用
- Faruki H, Mayhew GM, Serody JS, et al. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape. J Thorac Oncol. 2017. PMID: 28341226. doi:10.1016/j.jtho.2017.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。